Ohm, thanks for this. What are your thoughts on w
Post# of 145755
Could this explain the less than stellar therapeutic response in the 700mg LL arm of the MASH/NASH trial along with sample size and possible single allele delta 32 deletions in some of the patients?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)